Continuous glucose monitors (CGM) are a valuable tool, allowing people with diabetes to stay informed to make decisions without having to constantly prick their fingers...

Results from the Diabetes Technology Society’s Blood Glucose Meter Surveillance Program identifies only six out of 18 meters that passed. Did yours make the cut?

A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...

The Libre Sense CGM is similar to the Freestyle Libre 2, but it’s made for athletes and not for people with diabetes

A recent research study on open-source AID, a method of insulin delivery used by thousands of people with type 1 diabetes, showed that using open-source AID improved...

How this online program is a leader in digital health for programs based on the CDC’s National Diabetes Prevention efforts. Plus, a bonus interview with CEO Sean Duffy!

The Omnipod 5 automated insulin delivery system has been cleared by the FDA for people with type 1 diabetes. The system, which includes a tubeless insulin pump, a Dexcom...

Insulet recently announced that the Omnipod 5 automated insulin delivery (AID) system is now fully available to anyone with type 1 diabetes ages 2 and up. Read about...

El 27 de julio, Dexcom anunció el lanzamiento de la aplicación móvil Dexcom G6 en español, disponible para cualquier persona con un teléfono inteligente. Los usuarios de...

On July 27, Dexcom announced the launch of the Dexcom G6 mobile app in Spanish, available for anyone with a smartphone. Dexcom CGM users can now choose to view their...

Spinal cord stimulators, a type of implantable device, have been researched as a treatment for painful diabetic neuropathy, a complication of diabetes that leads to...

Earlier this week, Dexcom announced its decision to re-submit the software for the much-anticipated G7, pushing back the US launch date until later in 2022. Here’s why...

diaTribe’s Julie Heverly had the opportunity to try the new Tandem mobile app, which allows users to administer insulin boluses directly from their smartphones. Here’s...

A fully virtual six-month clinical trial is recruiting 300 people with type 1 and type 2 diabetes who are interested in trying continuous glucose monitoring (CGM) with...

Automated insulin delivery (AID) systems have helped many people with diabetes improve their glucose management and Time in Range, both during the day and overnight...

An update to Tandem’s t:connect mobile app, which allows users to administer bolus insulin directly from their smartphones, is now available for iOS and Android. To find...

Insulin pens and pumps are two of the most popular choices for insulin delivery. The CeQur Simplicity aims to combine the strengths of both of these technologies.

Vertex Pharmaceuticals announced its intention to acquire the biotechnology company ViaCyte for $320 million in cash, merging two leaders in beta cell replacement...

See if you are eligible to participate in this study looking at whether the One Touch Solutions platform and its associated partner programs can help people better...

What should you do if you need to switch from an insulin pump to manual injections due to a malfunction? Get tips and advice from an endocrinologist and diabetes expert...